鶹AV

Please note: The Research + Innovation office will be closed for the holidays from noon on December 24 through January 2nd, inclusive. ❄️ Veuillez noter que le bureau de la Recherche et de l'Innovation sera fermé pour les vacances du 24décembre à midi jusqu’au 2janvier inclus.

CIHR funds 鶹AV research to understand health effects of vaping

Three 鶹AV research projects received funding from CIHR to understand the overall health effects of vaping and determine whether vaping is linked to different outcomes for patients experiencing COVID-19 infections
Image by Thorn Yang from Pexels.

The (CIHR), in partnership with the , recently announced the results of their rapid response funding opportunity. The grant opportunity was developed to provide funding for research aimed at further understanding the health effects of vaping in response to growing concerns about the rapid rise of vaping in Canada and the associated health effects.

There is an increased need for research evidence to advance the understanding of vaping behaviours, associated health effects like lung illness or injury, vascular changes, and impact on mental health and addiction. In total, the CIHR invested $2.7 million in 27 grants across Canada, with the hopes that the research projects chosen will help inform future development of policies, practices and programs related to vaping.

Three 鶹AV studies received close to $300,000 in total funding from this opportunity, to study the effects of vaping. This funding opportunity is timely given that COVID-19 infections are known to negatively impact lung health. Two of the 鶹AV studies focus on whether vaping can be linked to different outcomes for patients dealing with COVID-19 infections.

鶹AV’s recipients:

; $99,984

, Professor in the Department of Medicine and Senior Investigator at the Lady Davis Institute Centre for Clinical Epidemiology and Community, is the principal investigator.

; $100,000

Professors Koren Mann of the Department of Oncology and Carolyn Baglole of the Department of Medicine, are the principal investigators.

; $100,000

Professor Ajitha Thanabalasuriar of the Department of Pharmacology and Therapeutics, is the principal investigator.

Back to top